OxFORD Asset Management LLP trimmed its holdings in shares of Cigna Corporation (NYSE:CI) by 91.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,959 shares of the health services provider’s stock after selling 72,599 shares during the period. OxFORD Asset Management LLP’s holdings in Cigna Corporation were worth $1,165,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. American Beacon Advisors Inc. bought a new stake in shares of Cigna Corporation during the first quarter worth approximately $102,000. Parallel Advisors LLC raised its stake in shares of Cigna Corporation by 62.3% during the second quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock worth $139,000 after buying an additional 307 shares during the last quarter. Guardian Life Insurance Co. of America raised its stake in shares of Cigna Corporation by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock worth $145,000 after buying an additional 7 shares during the last quarter. Acrospire Investment Management LLC raised its stake in shares of Cigna Corporation by 66.7% during the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the health services provider’s stock worth $167,000 after buying an additional 400 shares during the last quarter. Finally, Financial Architects Inc raised its stake in shares of Cigna Corporation by 186.0% during the second quarter. Financial Architects Inc now owns 1,121 shares of the health services provider’s stock worth $188,000 after buying an additional 729 shares during the last quarter. 87.94% of the stock is owned by institutional investors and hedge funds.
Cigna Corporation (NYSE CI) opened at 186.96 on Friday. Cigna Corporation has a 12-month low of $115.03 and a 12-month high of $193.00. The stock has a 50 day moving average of $184.96 and a 200 day moving average of $169.85. The firm has a market cap of $47.07 billion, a PE ratio of 21.57 and a beta of 0.43.
Cigna Corporation (NYSE:CI) last released its quarterly earnings data on Friday, August 4th. The health services provider reported $2.91 earnings per share for the quarter, beating the consensus estimate of $2.48 by $0.43. The company had revenue of $10.32 billion during the quarter, compared to analyst estimates of $10.26 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. Cigna Corporation’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.98 EPS. On average, equities research analysts anticipate that Cigna Corporation will post $10.03 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “OxFORD Asset Management LLP Sells 72,599 Shares of Cigna Corporation (CI)” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://www.tickerreport.com/banking-finance/2957101/oxford-asset-management-llp-sells-72599-shares-of-cigna-corporation-ci.html.
In other news, insider Jason D. Sadler sold 37,756 shares of Cigna Corporation stock in a transaction on Monday, August 7th. The shares were sold at an average price of $176.16, for a total value of $6,651,096.96. Following the completion of the sale, the insider now owns 47,844 shares in the company, valued at approximately $8,428,199.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Chairman Isaiah Harris, Jr. sold 247 shares of Cigna Corporation stock in a transaction on Tuesday, September 12th. The shares were sold at an average price of $185.27, for a total transaction of $45,761.69. The disclosure for this sale can be found here. Insiders sold a total of 70,653 shares of company stock valued at $12,437,684 in the last quarter. 1.30% of the stock is currently owned by company insiders.
A number of research firms recently weighed in on CI. UBS AG reissued a “buy” rating and set a $193.00 price target (up from $186.00) on shares of Cigna Corporation in a research note on Thursday, June 22nd. Royal Bank Of Canada reissued a “buy” rating and set a $185.00 price target on shares of Cigna Corporation in a research note on Wednesday, August 9th. Deutsche Bank AG boosted their price target on shares of Cigna Corporation from $180.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday, August 7th. Zacks Investment Research downgraded shares of Cigna Corporation from a “buy” rating to a “hold” rating in a research note on Tuesday, August 8th. Finally, Citigroup Inc. boosted their price target on shares of Cigna Corporation from $185.00 to $198.00 and gave the stock a “buy” rating in a research note on Monday, August 7th. One research analyst has rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $190.27.
Cigna Corporation Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.